Realtime | Geld | Brief | Zeit |
---|---|---|---|
0,198 | 0,206 | 22.02. |
Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
10.02. | SpineGuard Announces the Commercial Launch of its "PsiFGuard" New Smart Drilling Device Dedicated to Sacroiliac Joint Fusion | 212 | Business Wire | Innovation developed in partnership with the US company Omnia Medical Omnia launched PsiFGuard at the NANS convention in Orlando, from Jan. 30th to Feb. 1st, 2025
Regulatory News:
SpineGuard... ► Artikel lesen | |
10.01. | SpineGuard Reports Its Full-Year 2024 Revenue | 402 | Business Wire | +8% growth globally, +20% in the US
Regulatory News:
SpineGuard (FR0011464452 ALSGD), an innovative company that deploys its DSG (Dynamic Surgical Guidance) local conductivity sensing technology... ► Artikel lesen | |
07.01. | SpineGuard Completes a Bond Financing to Support the Deployment of Its New Products | 791 | Business Wire | Regulatory News:
SpineGuard (FR0011464452 ALSGD), an innovative company that deploys its DSG® (Dynamic Surgical Guidance) local conductivity sensing technology to secure and streamline the placement... ► Artikel lesen | |
SPINEGUARD Aktie jetzt für 0€ handeln | |||||
06.01. | SpineGuard and Omnia Medical Announce the Extension of Their Strategic Partnership | 287 | Business Wire | Scope of initial agreement extended to other products and countries Reallocation of personnel and resources to bolster the launch of Omnia products in the United States including PsiFGuard
Regulatory... ► Artikel lesen | |
03.01. | SpineGuard announces its 2025 financial calendar | 313 | Business Wire | Regulatory News:
SpineGuard (FR0011464452 ALSGD), an innovative company that deploys its DSG® (Dynamic Surgical Guidance) local conductivity sensing technology to secure and streamline the placement... ► Artikel lesen | |
09.10.24 | SpineGuard Announces Its Q3 2024 Revenue | 444 | Business Wire | Growth acceleration to continue in Q3 2024: +20% globally and +30% in the US Revenue up +13% over the first 9 months, to €3.6 million
Regulatory News:
SpineGuard (FR0011464452 ALSGD)... ► Artikel lesen | |
30.09.24 | SpineGuard Obtains FDA Clearance for Commercial Release of Its "PsiFGuard" New Smart Drilling Device Dedicated to Sacroiliac Joint Fusion | 407 | Business Wire | Innovation developed in partnership with the US company Omnia Medical Key milestone for the deployment of the DSG technology in the United States
Regulatory News:
SpineGuard (FR0011464452... ► Artikel lesen | |
11.09.24 | SpineGuard Reports its H1 2024 Financial Results | 343 | Business Wire | Revenue growth by 10% at constant exchange rate Net loss reduced by 20% and EBITDA improved by 30%
Regulatory News:
SpineGuard (FR0011464452 ALSGD), an innovative company that deploys... ► Artikel lesen | |
03.09.24 | SpineGuard obtains EC-MDR certification and launches its Threaded PediGuard for anterior spine surgery in Europe | 463 | Business Wire | Regulatory News:
SpineGuard (Paris:ALSGD)(FR0011464452 ALSGD), an innovative company that deploys its DSG® (Dynamic Surgical Guidance) local conductivity sensing technology to secure and streamline... ► Artikel lesen | |
17.07.24 | SpineGuard Files Its "510K" Dossier in the US for the Clearance of Its New Smart Drilling Device Dedicated to Sacroiliac Joint Fusion | 601 | Business Wire | Innovation developed in partnership with the US company Omnia Medical Acceleration of commercial deployment of SpineGuard in the United States
Regulatory News:
SpineGuard (FR0011464452... ► Artikel lesen | |
15.07.24 | SpineGuard Announces its H1 2024 Revenue | 277 | Business Wire | Growth acceleration in Q2, +14% globally (+26% in the US) 10% growth at constant exchange rate in the first half
Regulatory News:
SpineGuard (FR0011464452 ALSGD), an innovative company... ► Artikel lesen | |
26.06.24 | SpineGuard Reports on Its Annual Shareholders' Meeting of June 26, 2024 | 351 | Business Wire | Regulatory News:
SpineGuard (FR0011464452 ALSGD), an innovative company that deploys its DSG® (Dynamic Surgical Guidance) local conductivity sensing technology to secure and streamline the placement... ► Artikel lesen | |
20.06.24 | XFRA CAPITAL ADJUSTMENT INFORMATION - 20.06.2024 | 548 | Xetra Newsboard | Das Instrument LPHG LU1834988351 LIF-600 PER.+H. EOA ETF wird cum Kapitalmassnahme gehandelt am 20.06.2024 und ex Kapitalmassnahme am 21.06.2024 The instrument LPHG LU1834988351 LIF-600 PER.+H. EOA... ► Artikel lesen | |
17.04.24 | SpineGuard Announces Its Full-Year 2023 Financial Results and Its First Quarter 2024 Sales | 435 | Business Wire | Innovation and US investment in 2023 1Q24 sales back to growth +6% globally, +23% in the US
Regulatory News:
SpineGuard (FR0011464452 ALSGD), an innovative company that deploys its... ► Artikel lesen | |
05.03.24 | SpineGuard Reaches a Significant Regulatory Milestone to Strenghthen its PediGuard Offering in China | 450 | Business Wire | Submission of a file to the Chinese authorities (NMPA) to obtain renewed approval for the currently available range of PediGuard in China, as well as its extension to add the Curved and XS PediGuard... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
FRESENIUS | 36,490 | +0,19 % | Fresenius - Hoch geht's auf der Bewertungsleiter | Beim Gesundheitskonzern Fresenius sind Anleger derzeit bereit, für die Aktie einen höheren Preis zu zahlen. Dadurch klettert das DAX-Papier auf der Bewertungstreppe nach oben. Wir erklären, woran das... ► Artikel lesen | |
SIEMENS HEALTHINEERS | 55,74 | +1,09 % | DAX-Check: Airbus, Hypoport, Knorr-Bremse, Kontron, Krones, Mercedes-Benz, SAP, Siemens Healthineers | Der DAX hat gestern das nächste Rekordhoch markiert. Das Niveau aber nicht halten können. Heute ist die Stimmung überwiegend freundlich. Auch wenn es durchwachsene Geschäftszahlen von zwei DAX-Konzernen... ► Artikel lesen | |
TELADOC HEALTH | 11,042 | +0,47 % | Teladoc Health (NYSE:TDOC) Sees Strong Trading Volume Following Analyst Upgrade | ||
THERMO FISHER | 509,40 | +0,06 % | Thermo Fisher CDR (CAD Hedged): Thermo Fisher CDR (CAD Hedged) estimates distribution | ||
EUROFINS SCIENTIFIC | 48,490 | +0,50 % | Research and Markets: Europe Genome Sequencing Market Analysis and Forecasts 2024 & 2025-2033, Competition Synopsis of Eurofins Scientific, F. Hoffmann-La Roche, OncoDNA, Oxford Nanopore Technologies, and QIAGEN - ResearchAndMarkets.com | The "Europe Genome Sequencing Market: Focus on Product, End User, and Country Analysis and Forecast: 2024-2033" report has been added to ResearchAndMarkets.com's offering.
The Europe genome sequencing... ► Artikel lesen | |
SYNLAB | 11,320 | -1,05 % | Schock-News für Synlab Anleger vor dem Wochenende: So müssen Sie heute noch auf diese Sondermeldung reagieren! | ||
DAVITA | 135,10 | -0,73 % | DaVita-Aktie mit Kursverlusten (142,1692 €) | An der US-amerikanischen Börse notiert das Wertpapier von DaVita aktuell leichter. Zuletzt zahlten Investoren für die Aktie 148,49 US-Dollar. Der Anteilsschein von DaVita verzeichnet gegenwärtig ein... ► Artikel lesen | |
SPINEWAY | 0,114 | +0,44 % | Spineway: 2024 revenue of €12 million - 14% growth compared with 2023 | Press release Ecully, January 22, 2025 - 6.30 p.m. SPINEWAY 2024 revenue of €12 million 14% growth compared with 2023 In thousands of euros20242023Change as a %H1 revenue6,5355,431+20%H2... ► Artikel lesen | |
DENTSPLY SIRONA | 18,090 | +1,00 % | Dentsply Sirona Explores Strategic Options For Wellspect Healthcare | YORK (PENNSYLVANIA) (dpa-AFX) - Dentsply Sirona (XRAY) Tuesday announced the launch of a strategic review process for its Wellspect Healthcare business, a provider of bladder and bowel management... ► Artikel lesen | |
SMITH & NEPHEW | 12,570 | -0,04 % | Smith & Nephew UK Ltd: Smith+Nephew steps forward with innovative Sports Medicine foot & ankle repair solutions in Australia and New Zealand | ||
SONIC HEALTHCARE | 16,798 | +2,87 % | Sonic Healthcare H1 Net Profit Increases | ||
ONTRAK | 1,590 | -2,45 % | Ontrak Health Announces 2024 Third Quarter Financial Results | MIAMI--(BUSINESS WIRE)--Ontrak, Inc. (NASDAQ: OTRK) ("Ontrak" or the "Company"), a leading AI-powered and technology-enabled behavioral healthcare company, today reported its financial results... ► Artikel lesen | |
DIASORIN | 99,66 | +0,73 % | Deutsche Bank sets DiaSorin stock Buy rating, €121 target | ||
PATTERSON COMPANIES | 29,400 | 0,00 % | Patterson Companies Announces Expiration of "Go-Shop" Period | ST. PAUL, Minn.--(BUSINESS WIRE)--Patterson Companies, Inc. (Nasdaq: PDCO), a leading dental and animal health distributor, today announced the expiration of the 40-day "go-shop" period under the... ► Artikel lesen | |
FULGENT GENETICS | 16,400 | +3,80 % | Fulgent Reports Third Quarter 2024 Financial Results | EL MONTE, Calif.--(BUSINESS WIRE)--Fulgent Genetics, Inc. (NASDAQ: FLGT) ("Fulgent," or the "Company"), a technology-based company with a well-established laboratory services business and a therapeutic... ► Artikel lesen |